NCT01967459

Brief Summary

Administration of vitamin D will have a beneficial effect on postprandial leukocyte activation, oxidative stress and arterial stiffness in vitamin D deficient females. High doses of vitamin D may have a more pronounced effect than low doses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

October 17, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 23, 2013

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

October 5, 2017

Status Verified

October 1, 2017

Enrollment Period

2.2 years

First QC Date

October 17, 2013

Last Update Submit

October 4, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • effect of vitamin D on leukocyte cluster of differentiation antigen 11b expression

    the differential effect of 75 000 IU low dose vs. 300 000 IU high dose vitamin D on postprandial leukocyte activation markers cluster of differentiation antigen 11b

    2, 4, 6 and 8 hours postprandial

Secondary Outcomes (2)

  • Effect of vitamin D on oxidative stress

    2,4,6 and 8 hours postprandial

  • Effect of vitamin D on vascular function

    0,2,6,8 and 8 hours postprandial

Study Arms (2)

High dose vitamin D

ACTIVE COMPARATOR

Volunteers assigned to this arm will receive a single dose of oral cholecalciferol 300 000 IU, in the form of 3 ml D-cura drink 100 000 IU/ml

Drug: Cholecalciferol

Low dose vitamin D

ACTIVE COMPARATOR

Volunteers assigned to this arm will receive a single dose of oral cholecalciferol 75000 IU, in the form of 3 ml D-cura drink 25 000 IU/ml

Drug: Cholecalciferol

Interventions

Single dose D-cura cholecalciferol drink 100 000 IU/ml, in total 300 000 IU (=3ml)

Also known as: D-cura
High dose vitamin D

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 18 years or older;
  • Pre-menopausal;
  • BMI ≥25.0 kg/m2;
  • Vitamin D deficiency, defined by a 25-hydroxyvitamin D level of \<30ng/ml;
  • Use of oral contraceptives.

You may not qualify if:

  • The use of any kind of medication except oral contraceptives;
  • Smoking;
  • Pregnancy;
  • The use of (multi)vitamin supplements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sint Franciscus Gasthuis

Rotterdam, South Holland, 3045 PM, Netherlands

Location

MeSH Terms

Conditions

Atherosclerosis

Interventions

Cholecalciferol

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Officials

  • Manuel Castro Cabezas, MD, PhD

    Sint Franciscus Gasthuis

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 17, 2013

First Posted

October 23, 2013

Study Start

October 1, 2013

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

October 5, 2017

Record last verified: 2017-10

Locations